Fluid overload is associated with increased 90-day mortality in AML patients undergoing induction chemotherapy. Ballo O, Eladly F, Koschade S, Buttner S, et al. Ann Hematol 2021;100:2603-2611.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Ballo O, Eladly F, Koschade S, Buttner S, et al. Fluid overload is associated with increased 90-day mortality in AML patients undergoing induction chemotherapy. Ann Hematol 2021;100:2603-2611.
PMID: 34304288